MDR - Biomet Cannulated Screws

Sponsor
Zimmer Biomet (Industry)
Overall Status
Enrolling by invitation
CT.gov ID
NCT04002518
Collaborator
(none)
300
3
41.9
100
2.4

Study Details

Study Description

Brief Summary

The objective of this retrospective enrollment/prospective follow up study is to collect data confirming safety, performance, and clinical benefits of the Biomet Cannulated Bone Screw System (Implants and Instrumentation) when used according to the approved Indications for Use (IFU).

Condition or Disease Intervention/Treatment Phase
  • Device: Biomet Cannulated Screw: 3.0, 4.0, 5.0, 6.5, and 8.0mm screws.

Detailed Description

The objective of this retrospective enrollment/prospective follow up study is to collect data confirming safety, performance, and clinical benefits of the Biomet Cannulated Bone Screw System (Implants and Instrumentation) when used according to the approved Indications for Use (IFU).

Safety will be established by recording the incidence and frequency of complications and adverse events. Relationship of the events to either implant or instrumentation should be specified.

Performance and clinical benefits will be assessed by analyzing fracture healing/fusion and the overall pain and functional performance of subjects who received the Biomet Cannulated Bone Screws by recording survey questions. Zimmer Biomet defines the expected performance rate for Cannulated Screws for long and small bone fractures to be a union rate of at least 81% at 8-12 months.

Study Design

Study Type:
Observational
Anticipated Enrollment :
300 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Post-market Clinical Follow-up Study to Provide Safety, Performance and Clinical Benefits Data of the Biomet Cannulated Bone Screw System (Implants and Instrumentation) - A Retrospective/Prospective Study
Actual Study Start Date :
Aug 7, 2019
Anticipated Primary Completion Date :
Feb 1, 2023
Anticipated Study Completion Date :
Feb 1, 2023

Arms and Interventions

Arm Intervention/Treatment
3.0mm and 4.0mm

Patients who have surgically been treated with a 3.0mm or 4.0mm screw.

Device: Biomet Cannulated Screw: 3.0, 4.0, 5.0, 6.5, and 8.0mm screws.
Treatment of identified conditions, i.e. fracture fixation, arthrodesis, osteotomy, with a cannulated screw.

5.0mm

Patients who have surgically been treated with a 5.0mm screw.

Device: Biomet Cannulated Screw: 3.0, 4.0, 5.0, 6.5, and 8.0mm screws.
Treatment of identified conditions, i.e. fracture fixation, arthrodesis, osteotomy, with a cannulated screw.

6.5mm and 8.0mm

Patients who have surgically been treated with a 6.5mm or 8.0mm screw.

Device: Biomet Cannulated Screw: 3.0, 4.0, 5.0, 6.5, and 8.0mm screws.
Treatment of identified conditions, i.e. fracture fixation, arthrodesis, osteotomy, with a cannulated screw.

Outcome Measures

Primary Outcome Measures

  1. Device Safety Assessed Through the Incidence and Frequency of Revisions, Complications, and Adverse Events [Out to12+ months]

    Assessment of safety by recording and analyzing the incidence and frequency of revisions, complications, and adverse events.

Secondary Outcome Measures

  1. Device Performance and Clinical Benefits Assessed by a Patient Questionnaire Case Report Form [Out to 12+ months]

    Performance and clinical benefits demonstrated by the assessment of survey questions.

  2. Device Performance and Clinical Benefits Assessed by a Follow-Up Analysis Case Report Form [Out to 12+ months]

    Performance and clinical benefits demonstrated by the assessment of fracture healing/fusion and survey questions.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient must be 18 years of age or older.
All patients operated on for the following indications:
  • Group 1, Small Cannulated Screws (4.0mm and smaller diameter) are intended for use in:
  1. Fixation of small bones, including those in the foot, patella, ankle, wrist and elbow.

  2. Arthrodesis of the foot, wrist and elbow.

  3. Small and long bone osteotomies.

  4. Fracture fixation of small bones, small bone fragments and long bones.

  • Group 2, Large Cannulated Screws (5mm and larger in diameter) are intended for use in:
  1. Fixation of fractures in long bones and long bone fragments.

  2. Long bone osteotomies (femur, tibia, foot, ankle, olecranon).

  3. Arthrodesis and fracture fixation of the foot and ankle, such as Jones fractures of the fifth metatarsal, and Calcaneal fractures.

  • Group 3, Large Cannulated Screws (6.5mm and larger in diameter) are intended for use in:
  1. Slipped capital femoral epiphysis

  2. Pediatric femoral neck fractures

  3. Tibial plateau fractures

  4. SI joint disruptions

  5. Intercondylar femur fractures

  6. Subtalar arthrodesis

  7. Fixation of pelvis and iliosacral joint

  • Patients must have the ability and willingness to follow instructions, including control of weight and activity levels.

  • Patient must have a good nutritional state.

Exclusion Criteria:
  • Infections.

  • Patient conditions including blood supply limitations, insufficient quantity or quality of bone.

  • Patients with mental or neurologic conditions who are unwilling or incapable fo following postoperative care instructions.

  • Foreign body sensitivity where material sensitivity is suspected or unknown, testing is to be completed prior to implantation of the device.

  • Patient is a prisoner.

  • Patient is a current alcohol or drug abuser.

  • Patient is known to be pregnant or breastfeeding.

  • Patient has a psychiatric illness or cognitive deficit that will not allow for proper informed consent.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Zimmer Biomet Warsaw Indiana United States 46580
2 Orthopedic Foot and Ankle Center Worthington Ohio United States 43085
3 Associated Foot & Ankle Centers of Northern Virginia Lake Ridge Virginia United States 22192

Sponsors and Collaborators

  • Zimmer Biomet

Investigators

  • Study Director: Jarrod Hunnicutt, Zimmer Biomet

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Zimmer Biomet
ClinicalTrials.gov Identifier:
NCT04002518
Other Study ID Numbers:
  • MDRG2017-89MS-35T
First Posted:
Jun 28, 2019
Last Update Posted:
Mar 21, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 21, 2022